The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).
Horsham, PA, USA (Vocus) August 20, 2009 -- The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).
This three-day workshop will feature interactive discussions with government, biopharmaceutical, medical device, and data standards experts on how to ensure compliance and improve efficiency in clinical trial disclosure.
- Global Requirements, Laws, Regulations and Business Cases
- Defining the Clinical Trial Disclosure Role within a Company
- Available Tools, Resources, Organizations
- Impact of External Stakeholders, Company Policies, and Advanced Technologies on
- Disclosure Processes
- Key Milestones for Managing Compliance
- Quality Checks
"Evolving clinical trial registration and results disclosure requirements are significantly increasing the workload of clinical operations and medical affairs departments," says Program Co-chair Tracy Beck, PhD, Associate Global Medical Business Office Consultant; CTR Results Gatekeeper, Eli Lilly and Company. "This workshop will present real-world approaches to the clinical trial registration and results disclosure process."
A preconference tutorial titled, Clinical Trial Results Registration, will be held on October 6. This hands-on tutorial is designed to guide participants in creating accurate and effective study results to www.ClinicalTrials.gov.
For tabletop exhibit opportunities contact Jeff Korn at Jeff.Korn(at)diahome(dot)org.
Click here to register for the 3rd Annual Clinical Trial Disclosure Workshop.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
# # #
Read the full story at http://www.prweb.com/releases/DIA/clinical_trial_disclosure/prweb2775064.htm.
Related medicine news :1
Copyright©2009 Vocus, Inc.
All rights reserved
. Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival2
. Lightspeed Research -- The Foresight Group, Announced Today the Annual Meeting for The Healthcare Consortium3
. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting4
. Rodman Renshaw Annual Global Investment Conference in New York on September 10, 20095
. Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES Contra El Cancers EL SUENO DE ESPERANZA Gala6
. The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant7
. The Dannon Company Awards Fourth Annual Dannon Next Generation Nutrition Grants Supporting Nutrition Education for Children8
. Sebastian Ferrero Foundation to Host 2nd Annual Fundraiser, Noche de Gala9
. Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention10
. VA Secretary Addresses 65th Annual AMVETS Convention11
. Scott Hamiltons Return to the Ice Scheduled for the 10th Annual An Evening With Scott Hamilton and Friends on Saturday, Nov. 7, 2009